Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Homocysteine, a well-known inducer of vascular endothelial cell damage has been associated with extracellular matrix changes. Many studies demonstrated that high levels of this aminoacid in diabetic patients increases significantly the risk of the development of this pathology. This study has been undertaken to investigate the role of homocysteine and its cofactors (folic acid, vitamin B6 and B12) during the progression of the diabetic retinopathy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Catania
• Treatments: Folic Acid; Pyridoxine; Vitamin B 6; Vitamin B Complex

Criteria

Inclusion Criteria:

• diabetic patients with proliferative and non proliferative retinopathy

Exclusion Criteria:

• Patients with chronic liver disease Patients with kidney disease.